drugset / Trial / NCT00512707

Effect of Testosterone in Men With Erectile Dysfunction

NCT00512707 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this placebo-controlled study is to determine if testosterone replacement therapy, administered by transdermal gel, can improve the response to sildenafil (Viagra R) treatment in men who have erectile dysfunction (ED) and low testosterone levels.

Timeline

Start
2006-11
Primary completion
2010-05
Completion
2010-05

Outcome

Missed primary endpoint

paper change in EFD score after randomization did not differ between the groups (difference, 2.2 [CI, -0.8 to 5.1]; P = 0.150). PMID 23165659 ↗

paper Sildenafil plus testosterone was not superior to sildenafil plus placebo in improving erectile function PMID 23165659 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 25 mg Oral
Subject Sildenafil Unknown 50 mg Oral
Subject Sildenafil Unknown 100 mg Oral
Subject Testosterone Small molecule 5 g Other
Subject Testosterone Small molecule 10 g Other
Subject Testosterone Small molecule 15 g Other